Scleromyxoedema—successful treatment with plasma exchange and immunosuppression
- 1 November 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 117 (5) , 653-657
- https://doi.org/10.1111/j.1365-2133.1987.tb07499.x
Abstract
A 34-year-old woman with scleromyxoedema failed to respond to initial treatment with cyclophosphamide or psoralen-UVA photochemotherapy (PUVA). She developed neurological symptoms which resolved after five 41 plasma exchanges performed on successive days, together with pulse methylprednisolone therapy. Subsequent treatment was with oral prednisolone and cyclophosphamide. She had had no further episodes of neurological dysfunction 8 months after plasma exchange, and the appearance of the skin had improved almost to normal. The complications and difficulty in management of scleromyxoedema are discussed.This publication has 15 references indexed in Scilit:
- PUVA treatment of scleromyxoedemaBritish Journal of Dermatology, 1984
- Electron-beam treatment of scleromyxoedemaBritish Journal of Dermatology, 1982
- Papular mucinosis. A clinicopathologic study of four patientsArchives of Dermatology, 1982
- Spontaneous resolution of lichen myxoedematosusBritish Journal of Dermatology, 1979
- Lichen Myxedematosus Serum Stimulates Human Skin Fibroblast ProliferationScience, 1978
- Successful management of lichen myxedematosus. Report of a caseArchives of Dermatology, 1976
- ScleromyxedemaArchives of Dermatology, 1976
- Lich myxedematosus. A dermal infiltrative disorder responsive to cyclophosphamide therapyArchives of Dermatology, 1975
- Immunologic studies in lichen myxedematosusArchives of Dermatology, 1967
- Scleromyxedema. A variant of Lichen myxedematosusArchives of Dermatology, 1966